Hannah Baade

The telehealth company Teladoc Health Inc (NYSE: TDOC) has posted strong gains during the coronavirus pandemic.   The Teladoc Analyst: D.A. Davidson analyst Hannah Baade initiated coverage of Teladoc with a Buy rating and $250 price target. The Teladoc Thesis: Teladoc, being a pure...